4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt
[CAS# 161558-45-8]

Identification

• Classification: Organic raw materials >> Heterocyclic compound >> Piperidines
• Name: 4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt
• Synonyms: 2-[(4-chlorophenyl)-piperidin-4-yloxymethyl]pyridine 4-nitrobenzoic acid
• Molecular Formula: C₁₇H₁₉ClN₂O^.C₇H₅NO₄
• Molecular Weight: 469.92
• CAS Registry Number: 161558-45-8
• SMILES: C1CNCCC1OC(C2=CC=C(C=C2)Cl)C3=CC=CC=N3.C1=CC(=CC=C1C(=O)O)[N+](=O)[O-]

Safety Data

• Hazard Symbols: GHS07 Warning
• Hazard Statements: H302-H315-H319-H335
• Precautionary Statements: P261-P305+P351+P338

Discovory and Applicatios

4-[(4-Chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt is a chemical compound that has gained interest in scientific research due to its potential applications in pharmacology and medicinal chemistry. This substance, belonging to the class of piperidine derivatives, is primarily explored for its effects on neurological and cardiovascular systems, although its full therapeutic potential is still under investigation.

The compound is characterized by a piperidine ring, a common structural motif in many biologically active molecules, which is linked to a methoxy group that connects a 4-chlorophenyl group and a 2-pyridyl group. The combination of these groups imparts specific chemical and pharmacological properties to the compound, which may influence its ability to interact with various receptors or enzymes in the human body.

The discovery of 4-[(4-chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt is part of an ongoing effort in the field of medicinal chemistry to identify new compounds that can act on neurotransmitter systems, particularly those related to dopamine, serotonin, or adrenergic receptors. Research into compounds like this one aims to develop new therapeutic options for a range of conditions, including neurological disorders, psychiatric diseases, and cardiovascular diseases.

One of the key applications of 4-[(4-chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt in research is its potential as a tool for studying receptor binding and neurotransmitter modulation. The presence of the pyridyl and chlorophenyl groups suggests that the compound may interact with receptors in the brain, potentially offering a means of modulating the nervous system in specific ways. This could make the compound useful in developing new treatments for diseases like Parkinson’s disease, schizophrenia, or depression.

Moreover, the nitrobenzoic acid salt form of the compound may enhance its solubility and stability, which are important factors for the drug development process. This form could potentially make the compound more suitable for in vivo testing and further clinical development. Additionally, as a salt, it may also influence the compound’s pharmacokinetics, such as absorption, distribution, metabolism, and excretion, all of which are crucial for determining its viability as a therapeutic agent.

The pharmacological profile of 4-[(4-chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt is still under investigation. Early studies suggest that it may have potential as a modulator of certain receptors or pathways involved in the regulation of neurotransmitters, though further research is necessary to fully understand its mechanisms of action. Given its structure, the compound may also show promise in the development of treatments for cardiovascular diseases, where receptor modulation can influence vascular tone and heart function.

In conclusion, 4-[(4-chlorophenyl)-2-pyridylmethoxy]piperidine p-nitrobenzoic acid salt represents an interesting compound in the field of medicinal chemistry with potential applications in neurology and cardiovascular health. Ongoing research into its receptor interactions and pharmacological effects will be crucial for determining its therapeutic potential in clinical settings.